These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 10717928

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
    Iakusevich VV, Mozheĭko ME, Paliutin ShKh, Berezina MIu, Martsevich SIu, Shal'nova SA, Deev AD, Kutishenko NP, Alimova EV, Koniakhina IP, Semenova IuE.
    Ter Arkh; 2000; 72(10):82-6. PubMed ID: 11220887
    [Abstract] [Full Text] [Related]

  • 5. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension.
    Valvo E, Gammaro L, Bedogna V, Tonon M, Giorgetti P, Pica B, Antonini P, Tessitore N, Oldrizzi L, Rugiu C.
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):656-9. PubMed ID: 2830196
    [Abstract] [Full Text] [Related]

  • 11. [Hypertension in patients with diabetes].
    Poulsen PL, Hansen KW, Gaede PH, Rossing P.
    Ugeskr Laeger; 2009 Jun 08; 171(24):2031-4. PubMed ID: 19523370
    [Abstract] [Full Text] [Related]

  • 12. [Are all antihypertensive drugs renoprotective?].
    Wolf S, Risler T.
    Herz; 2004 May 08; 29(3):248-54. PubMed ID: 15167950
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H, Kanno Y, Kaneko K, Kaneko M, Kotaki S, Mimura T, Takane H.
    Ther Apher Dial; 2004 Aug 08; 8(4):320-7. PubMed ID: 15274684
    [Abstract] [Full Text] [Related]

  • 14. ACE inhibition in diabetic patients: effect on pressor responsiveness to noradrenaline.
    Strocchi E, Malini PL, Ciavarella A, Valtancoli G, Ricci C, Mustacchio A, Vannini P, Ambrosioni E.
    J Hum Hypertens; 1992 Aug 08; 6(4):317-9. PubMed ID: 1433167
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Insulin and the renin-angiotensin-aldosterone system: influence of ACE inhibition.
    Ferrannini E, Seghieri G, Muscelli E.
    J Cardiovasc Pharmacol; 1994 Aug 08; 24 Suppl 3():S61-9. PubMed ID: 7700069
    [Abstract] [Full Text] [Related]

  • 17. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T.
    Hypertens Res; 2008 Jan 08; 31(1):59-67. PubMed ID: 18360019
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
    Jarmuzewska EA, Rocchi R, Guidoni A, Mangoni AA.
    Panminerva Med; 2008 Sep 08; 50(3):207-16. PubMed ID: 18927524
    [Abstract] [Full Text] [Related]

  • 20. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K.
    Vnitr Lek; 2007 Apr 08; 53(4):364-70. PubMed ID: 17578167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.